Why biotechs need a practical approach to going public

March 11, 2022

Sector: Life Sciences & Healthcare

David Diamond, audit committee chair and board member of Kreston Global US member, CBIZ MHM, has been published recently in Life Science Leader. David discusses the fast-track to the public market some bio-tech companies are now experiencing, after a renewed interest in the industry.

Read the article here (membership needed).